Cutera, Inc. Announces First Quarter 2021 Financial Results

May 5, 2021 at 4:01 PM EDT

 

BRISBANE, Calif.--(BUSINESS WIRE)--May 5, 2021-- Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the first quarter ended March 31, 2021.

First Quarter 2021 Financial and Operational Highlights

  • Revenue was $49.7 million, an increase of 54.1% from the prior-year period, driven by strong performance across the business, with particular strength in capital equipment and skincare sales.
    • Capital Equipment revenue of $28.3 million increased 35.1% over the prior-year period.
    • Recurring revenue, defined by the combination of Skincare, Consumable Products, and Service, was $21.3 million, an increase of 89.2% over the prior-year period:
      • Skincare revenue of $12.3 million increased 324.4% over the prior-year period;
      • Consumable Product revenue of $2.9 million grew 15.5% over prior-year period, reflecting the continued recovery of energy-based treatment volumes; and
      • Service revenue of $6.1 million increased 4.6% over the prior-year period.
  • Gross Margin was 55.8%, compared to 44.5% in the prior-year period, due to ongoing improvements in manufacturing efficiencies, offset by mix shift associated with growth of skincare during the quarter;
  • Operating Expenses were $26.5 million in the quarter, flat to prior-year period;
  • Adjusted EBITDA was $4.6 million in the period as compared to $(8.3) million, a $12.9 million improvement over prior-year period; and
  • Net loss was ($0.4) million, or ($0.02) per fully diluted share, compared to a net loss of ($12.4) million, or ($0.86) per fully diluted share, in the prior-year period;
  • Announced pricing of offering of $138.3 million of convertible senior notes.

“I am pleased with our first-quarter results, which reflect the continued progress we have made since the onset of the COVID-19 pandemic,” commented Dave Mowry, Chief Executive Officer of Cutera, Inc. “In the first-quarter, we achieved broad strength across our business, driven by consistent execution from our commercial teams, strength in the skincare business, and a slow but steady improvement in our end markets. Building upon the tremendous work from our team, in 2021 we plan to continue to improve gross margins by reducing manufacturing costs; increase sales and sales productivity with our focus on people and process; and deliver innovative products through our increased R&D investments. As we execute these vital few initiatives, our objective is to deliver strong performance despite the remaining pandemic uncertainties that will likely be headwinds for many of us in this market.”

2021 Outlook

Company management remains cautious with the lingering uncertainty related to COVID-19. Global Energy-based Aesthetics end markets continued to improve over the course of the first quarter, but the pace and extent of customer recovery varied by geography. With several geographies still under activity restrictions, management is not issuing full-year guidance at this time.

Conference Call

The Company’s management will host a conference call to discuss these results and related matters today at 1:30 p.m. PT (4:30 p.m. ET). Participating on the call will be Dave Mowry, Chief Executive Officer and Rohan Seth, Chief Financial Officer.

To participate in the conference call, dial 1-877-705-6003 (domestic) or + 1-201-493-6725 (international) and refer to the Conference Code: 13719080.

The call will also be webcast and can be accessed from the Investor Relations section of Cutera’s website at http://www.cutera.com/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

About Cutera, Inc. 

Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has developed innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

*Use of Non-GAAP Financial Measures

In this press release, in order to supplement the Companys condensed consolidated financial statements presented in accordance with Generally Accepted Accounting Principles, or GAAP, management has disclosed certain non-GAAP financial measures for the statement of operations and net income (loss) per diluted share. Non-GAAP adjustments include stock-based compensation, depreciation, amortization, executive and other non-recurring separation costs, customer relationship management (CRM) and enterprise resource planning (ERP) system costs, non-recurring legal and litigation costs, as well as the net tax impact of excluding these items. From time to time in the future, there may be other items that we may exclude if the Company believes that doing so is consistent with the goal of providing useful information to investors and management. The Company has provided a reconciliation of each non-GAAP financial measure used in this earnings release to the most directly comparable GAAP financial measure. The Company has not provided a reconciliation of non-GAAP guidance measures to the corresponding GAAP measures on a forward-looking basis due to the potential significant variability, limited visibility, unpredictability, or unique non-recurring nature of the items. Forward-looking non-GAAP measures include adjusted EBITDA. The Company defines adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, stock-based compensation, executive and other non-recurring separation costs, customer relationship management and enterprise resource planning system costs, and non-recurring legal and litigation costs.

Company management uses these measurements as aids in monitoring the Companys ongoing financial performance from quarter to quarter, and year to year, on a regular basis and for benchmarking against other similar companies. Non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. These non-GAAP financial measures should be considered along with, but not as alternatives to, the operating performance measure as prescribed by GAAP. Non-GAAP financial measures for the statement of operations and net income per diluted share exclude the following:

Non-cash expenses for stock-based compensation. The Company has excluded the effect of stock-based compensation expenses in calculating its non-GAAP operating expenses and net income measures. Although stock-based compensation is a key incentive offered to the Company's employees, the Company continues to evaluate its business performance excluding stock-based compensation expenses. The Company records stock-based compensation expense related to grants of options, employee stock purchase plan, and performance and restricted stock. Depending upon the size, timing and the terms of the grants, this expense may vary significantly but will recur in future periods. The Company believes that excluding stock-based compensation better allows for comparisons to its peer companies;

Depreciation and amortization. The Company has excluded depreciation and amortization expense in calculating its non-GAAP operating expenses and net income measures. Depreciation and amortization are non-cash charges to current operations;

Executive and other non-recurring separation costs. We have excluded costs associated with the resignation of our former Executive Officers in calculating our non-GAAP operating expenses and net income measures. We exclude these and other non-recurring employee separation costs because we believe that these items do not reflect future operating expenses;

Customer Relationship Management. We have excluded CRM system costs related to direct and incremental costs incurred in connection with our multi-phase implementation of a new CRM solution and the related technology infrastructure costs. We exclude these costs because we believe that these items do not reflect future operating expenses and will be inconsistent in amounts and frequency making it difficult to contribute to a meaningful evaluation of our operating performance;

Enterprise Resource Planning. We have excluded ERP system costs related to direct and incremental costs incurred in connection with our multi-phase implementation of a new ERP solution and the related technology infrastructure costs. We exclude these costs because we believe that these items do not reflect future operating expenses and will be inconsistent in amounts and frequency making it difficult to contribute to a meaningful evaluation of our operating performance; and

Non-recurring legal and litigation costs. We have excluded costs incurred related to third party litigation and disputes, that are of a non-recurring nature.

The Company believes that excluding all of the items above allows users of its financial statements to better review and assess both current and historical results of operations.

Safe Harbor Statement

Certain statements in this press release, other than purely historical information, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). These statements include, but are not limited to, Cuteras plans, objectives, strategies, financial performance and outlook, CFO and other senior leadership searches, product launches and performance, trends, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, the Companys actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as may, could, seek, guidance, predict, potential, likely, believe, will, should, expect, anticipate, estimate, plan, intend, forecast, foresee or variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond the Companys control, that could cause its actual results to differ materially from the forward-looking statements contained in this press release, including those described in the Risk Factors section of Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, the Registration Statement on Form S-,8 and other documents filed from time to time with the United States Securities and Exchange Commission by Cutera.

All information in this press release is as of the date of its release. Accordingly, undue reliance should not be placed on forward-looking statements. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. If the Company updates one or more forward-looking statements, no inference should be drawn that it will make additional updates with respect to those or other forward-looking statements. Cutera's financial performance for the first quarter ended March 31, 2021, as discussed in this release, is preliminary and unaudited, and subject to adjustment.

CUTERA, INC. 
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands) 
(unaudited) 
             
             
      March 31     December 31,
Reporting Unit Balance Sheet    

2021

   

2020

Assets            
Current assets:            
Cash and cash equivalents   $

                   164,932

   $ 

                  47,047

Accounts receivable, net    

                     24,151

   

                  21,962

Inventories    

                     34,578

   

                  28,508

Other current assets and prepaid expenses    

                     10,339

   

                    8,779

Total current assets    

                   234,000

   

                106,296

               
Property and equipment, net    

                       2,373

   

                    2,299

Deferred tax asset    

                          598

   

                       643

Goodwill    

                       1,339

   

                    1,339

Operating lease right-of-use assets    

                     16,570

   

                  17,076

Other long-term assets    

                       4,853

   

                    5,080

Total assets   $

                   259,733

   $ 

                132,733

             
Liabilities and Stockholders' Equity            
Current liabilities:            
Accounts payable   $

                       5,031

   $ 

                    6,684

Accrued liabilities    

                     41,329

   

                  31,079

Operating leases liabilities    

                       2,351

   

                    2,260

PPP Loan Payable    

                       6,352

   

                    3,630

Extended warranty liabilities    

                       1,039

   

                    1,216

Deferred revenue    

                     10,019

   

                    9,489

Total current liabilities    

                     66,121

   

                  54,358

             
Deferred revenue, net of current portion    

                       1,718

   

                    1,748

PPP Loan payable, net of current portion    

                          851

   

                    3,555

Operating lease liabilities, net of current portion    

                     15,394

   

                  15,950

Convertible note, net of unamortized debt issuance costs of $4,665    

                   133,585

   

 - 

Other long-term liabilities    

                          434

   

                       242

Total liabilities    

                   218,103

   

                  75,853

             
Stockholders’ equity:            
Common stock    

                            18

   

                         18

Additional paid-in capital    

                   102,206

   

                117,097

Accumulated deficit    

                    (60,594)

   

                (60,235)

Total stockholders' equity    

                     41,630

   

                  56,880

Total liabilities and stockholders' equity   $

                   259,733

   $ 

                132,733

             
     

                       -

   

                    -

CUTERA, INC. 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited) 
                
             
    Three Months Ended
             
    March 31,   March 31,
   

2021

 

2020

             
Products   $

           43,551

  $

26,391

Service    

             6,117

   

5,848

Total net revenue    

           49,668

   

32,239

             
Products    

           18,331

   

14,103

Service    

             3,627

   

3,800

Total cost of revenue    

           21,958

   

17,903

Gross profit    

           27,710

    

14,336

Gross margin %    

56%

   

44%

             
Operating expenses:             
Sales and marketing    

           15,068

   

14,789

Research and development    

             4,112

   

3,870

General and administrative    

             7,365

   

7,806

Total operating expenses    

           26,545

    

26,465

Income (loss) from operations    

             1,165

    

(12,129)

Interest and other expense, net            
Amortization of debt issuance costs    

                (52)

   

-

Interest on convertible notes    

              (191)

   

-

Other expense, net    

           (1,023)

   

(207)

Total Interest and other expense, net    

           (1,266)

   

(207)

Loss before income taxes    

              (101)

    

(12,336)

Income tax expense    

                258

   

78

Net loss   $

              (359)

   $

(12,414)

             
Net loss per share:            
Basic   $

             (0.02)

   $ 

(0.86)

Diluted   $

             (0.02)

   $ 

(0.86)

             
Weighted-average number of shares used in per share calculations:            
Basic    

           17,768

   

14,433

Diluted    

           17,768

   

14,433

CUTERA, INC. 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands) 
(unaudited) 
   
     Three Months Ended
    March 31,   March 31,
   

2021

 

2020

Cash flows from operating activities:            
Net loss   $

                      (359)

  $

         (12,414)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Stock-based compensation    

                     1,846

   

             1,980

Depreciation of tangible assets    

                        361

   

                360

Amortization of contract acquisition costs    

                        545

   

                717

Amortization of  debt issuance costs    

                          52

   

 - 

Impairment of capitalized cloud computing costs    

                        182

   

                     -

Change in deferred tax asset    

                          45

   

                  15

Provision for credit losses    

                        218

   

                590

Gain on sale of property and equipment    

                        (59)

   

 - 

Change in right-of-use asset    

                        604

   

                645

Other    

 - 

   

                  35

Changes in assets and liabilities:            
Accounts receivable    

                   (2,407)

   

             5,306

Inventories    

                   (6,021)

   

           (3,020)

Other current assets and prepaid expenses    

                   (1,560)

   

                807

Other long-term assets    

                      (500)

   

              (207)

Accounts payable    

                   (1,653)

   

             1,919

Accrued liabilities    

                   10,199

   

           (6,567)

Extended warranty liabilities    

                      (177)

   

              (234)

Operating lease liabilities    

                      (563)

   

              (645)

Deferred revenue    

                        500

   

           (1,253)

Net cash provided by (used in) operating activities    

                     1,253

   

         (11,966)

             
Cash flows from investing activities:            
Acquisition of property, equipment and software    

                      (101)

   

              (230)

Proceeds from disposal of property and equipment    

                          52

   

                     -

Proceeds from sales of marketable investments    

 - 

   

             6,800

Purchase of marketable investments    

 - 

   

           (3,930)

Net cash provided by (used in) investing activities    

                        (49)

   

             2,640

               
Cash flows from financing activities:            
Proceeds from exercise of stock options and employee stock purchase plan  

                        396

   

                201

Purchase of capped call    

                 (16,134)

   

                     -

Proceeds from issuance of convertible notes    

                 138,250

   

 - 

Payment of issuance costs of convertible notes    

                   (4,717)

   

 - 

Taxes paid related to net share settlement of equity awards    

                      (999)

   

           (2,234)

Payments on finance lease obligations    

                      (115)

   

              (183)

Net cash provided by (used in) financing activities    

                 116,681

   

           (2,216)

             
Net increase (decrease) in cash and cash equivalents    

                 117,885

   

         (11,542)

Cash and cash equivalents at beginning of period    

                   47,047

   

           26,316

Cash and cash equivalents at end of period   $

                 164,932

   $ 

           14,774

CUTERA, INC. 
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in thousands, except percentage data)
(unaudited) 
  
    Three Months Ended    % Change
    March 31   March 31   2021 Vs
   

2021

 

2020

 

2020

Revenue By Geography:                
North America   $

                    22,396

  $

                  15,373

  +46%
Japan    

                    16,555

   

                    7,162

  +131%
Rest of World    

                    10,717

   

                    9,704

  +10%
Total Net Revenue   $

                    49,668

  $

                  32,239

  +54%
Rest of World (including Japan) as a percentage of total revenue    

55%

   

52%

   
                   
Revenue By Product Category:                
Systems                
- North America   $

                    16,785

  $

                  10,382

  +62%
- Rest of World (including Japan)    

                    11,536

   

                  10,576

  +9%
Total Systems    

                    28,321

   

                  20,958

  +35%
Consumables    

                      2,925

   

                    2,533

  +15%
Skincare    

                    12,306

   

                    2,900

  +324%
Total Products    

                    43,552

   

                  26,391

  +65%
                 
Service    

                      6,116

   

                    5,848

  +5%
Total Net Revenue   $

                    49,668

  $

                  32,239

  +54%
                 
                 
                 
    Three Months Ended     
    March 31   March 31    
   

2021

 

2020

   
Pre-tax Stock-Based Compensation Expense:                
Cost of revenue   $

                         144

  $

                       290

   
Sales and marketing    

                         721

   

                       719

   
Research and development    

                         301

   

                       321

   
General and administrative    

                         680

   

                       650

   
    $

                      1,846

  $

                    1,980

   

CUTERA, INC. 

RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

TO  NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited) 

                                                       
                                   
    Three Months Ended March 31, 2021   Three Months Ended March 31, 2020
    GAAP   Depreciation
and
Amortization
  Stock-Based
Compensation
  CRM and ERP
Implementation
/write-off
  Legal - Lutronic   Taxes and
Other
Adjustments
    Non-GAAP   GAAP   Depreciation
and
Amortization
  Stock-Based
Compensation
  CRM and ERP
Implementation/
write-off
  Taxes and
Other
Adjustments
  Non-GAAP
                                                       
Net revenue  

 $

     49,668

 

 

 

                        -

 

 

 

                                -

 

 

 

                             -

 

 

 

                                     -

 

 

 

                        -

   

 $

              49,668

 

 

 $

          32,239

 

 

                        -

 

 

                           -

 

 

                                         -

 

 

                       -

 

 

 $

      32,239

 

Cost of revenue  

 

        21,958

 

 

 

                 (162

)

 

 

                          (144

)

 

 

                             -

 

 

 

                                     -

 

 

 

                        -

   

 

                 21,652

 

 

 

             17,903

 

 

                 (140

)

 

                     (290

)

 

                                         -

 

 

                       -

 

 

 

         17,473

 

Gross profit  

 

        27,710

 

 

 

                   162

 

 

 

                           144

 

 

 

                             -

 

 

 

                                     -

 

 

 

                        -

   

 

                 28,016

 

 

 

             14,336

 

 

                   140

 

 

                       290

 

 

                                         -

 

 

                       -

 

 

 

         14,766

 

Gross margin %  

 

56%

                       

 

56%

 

 

44%

                 

 

46%

                                                       
Operating expenses:                                                      
Sales and marketing  

 

        15,068

 

 

 

                 (678

)

 

 

                          (721

)

 

 

                      (182

)

 

 

                                     -

 

 

 

                        -

   

 

                 13,487

 

 

 

             14,789

 

 

                 (871

)

 

                     (718

)

 

                                   (165

)

 

                       -

 

 

 

         13,035

 

Research and development  

 

          4,112

 

 

 

                   (39

)

 

 

                          (301

)

 

 

                             -

 

 

 

                                     -

 

 

 

                        -

   

 

                   3,772

 

 

 

               3,870

 

 

                   (38

)

 

                     (321

)

 

                                         -

 

 

                       -

 

 

 

           3,511

 

General and administrative  

 

          7,365

 

 

 

                   (27

)

 

 

                          (680

)

 

 

                        (70

)

 

 

                               (401

)

 

 

                        -

   

 

                   6,187

 

 

 

               7,806

 

 

                   (28

)

 

                     (651

)

 

                                   (244

)

 

                 (324

)

 

 

           6,559

 

Total operating expenses  

 

        26,545

 

 

 

                 (744

)

 

 

                       (1,702

)

 

 

                      (252

)

 

 

                               (401

)

 

 

                        -

   

 

                 23,446

 

 

 

             26,465

 

 

                 (937

)

 

                  (1,690

)

 

                                   (409

)

 

                 (324

)

 

 

         23,105

 

Income (loss) from operations  

 

          1,165

 

 

 

                   906

 

 

 

                        1,846

 

 

 

                        252

 

 

 

                                 401

 

 

 

                        -

   

 

                   4,570

 

 

 

           (12,129

)

 

                1,077

 

 

                    1,980

 

 

                                    409

 

 

                  324

 

 

 

         (8,339

)

Interest and other expense, net                                                      
Amortization of debt issuance costs  

 

             (52

)

 

 

                        -

 

 

 

                                -

 

 

 

                             -

 

 

 

                                     -

 

 

 

                        -

   

 

                      (52

)

 

 

                      -

 

 

                        -

 

 

                           -

 

 

                                         -

 

 

                       -

 

 

 

                  -

 

Interest on convertible notes  

 

           (191

)

 

 

                        -

 

 

 

                                -

 

 

 

                             -

 

 

 

                                     -

 

 

 

                        -

   

 

                    (191

)

 

 

                      -

 

 

                        -

 

 

                           -

 

 

                                         -

 

 

                       -

 

 

 

                  -

 

Other expense, net  

 

        (1,023

)

 

 

                       -

 

 

 

                               -

 

 

 

                            -

 

 

 

                                     -

 

 

 

                       -

   

 

                 (1,023

)

 

 

                (207

)

 

                       -

 

 

                           -

 

 

                                        -

 

 

                      -

 

 

 

            (207

)

Total interest and other expense, net  

 

        (1,266

)

 

 

                        -

 

 

 

                                -

 

 

 

                             -

 

 

 

                                     -

 

 

 

                        -

   

 

                 (1,266

)

 

 

                (207

)

 

                        -

 

 

                           -

 

 

                                         -

 

 

                       -

 

 

 

            (207

)

Income (loss) before income taxes  

 

           (101

)

 

 

                   906

 

 

 

                        1,846

 

 

 

                        252

 

 

 

                                 401

 

 

 

                        -

   

 

                   3,304

 

 

 

           (12,336

)

 

                1,077

 

 

                    1,980

 

 

                                    409

 

 

                  324

 

 

 

         (8,546

)

Provision for income taxes  

 

             258

 

 

 

                       -

 

 

 

                               -

 

 

 

                            -

 

 

 

                                     -

 

 

 

                       -

   

 

                      258

 

 

 

                    78

 

 

                       -

 

 

                           -

 

 

                                        -

 

 

                      5

 

 

 

                83

 

Net income (loss)  

 $

        (359

)

 

 $

                906

 

 

 $

                     1,846

 

 

 $

                     252

 

 

 $

                              401

 

 

 $

                     -

   

 $

                3,046

 

 

 $

        (12,414

)

 

                1,077

 

 

                    1,980

 

 

                                    409

 

 

                  319

 

 

 $

      (8,629

)

                                                       
Net income (loss) per share:                                                      
Basic  

 $

       (0.02

)

                       

 $

                  0.17

 

 

 $

            (0.86

)

                 

 $

        (0.60

)

Diluted  

 $

       (0.02

)

                       

 $

                  0.15

 

 

 $

            (0.86

)

                 

 $

        (0.60

)

                                                       
Weighted-average number of shares used in per share calculations:                                                      
Basic  

 

        17,768

 

                       

 

                 17,768

 

 

 

             14,433

 

                 

 

         14,433

 

Diluted  

 

        17,768

 

                       

 

                 22,266

 

 

 

             14,433

 

                 

 

         14,433

 

                                                       
                                                       
                                                       
                                                       
Operating expenses as a % of net revenue   GAAP                         Non-GAAP   GAAP                   Non-GAAP
Sales and marketing  

30.3%

                       

27.2%

 

45.9%

                 

40.4%

Research and development  

8.3%

                       

7.6%

 

12.0%

                 

10.9%

General and administrative  

14.8%

                       

12.5%

 

24.2%

                 

20.3%

   

53.4%

                       

47.2%

 

82.1%

                 

71.7%

CUTERA, INC. 
RECONCILIATION OF LOSS TO ADJUSTED EBITDA
(in thousands)
(unaudited) 
       
       
    Three Months
Ended
   

March 31, 2021

       
Net loss  

 $

              (359

)

 
Adjustments:      
Stock-based compensation  

 

                1,846

 

 
Depreciation and amortization  

 

                   906

 

 
CRM and ERP implementation/ write off  

 

                   252

 

 
Legal - Lutronic  

 

                   401

 

 
Interest and other expense, net  

 

                1,266

 

 
Provision for income taxes  

 

                   258

 

 
Total adjustments  

 $

             4,929

 

 
       
Adjusted EBITDA  

 $

             4,570

 

 

 

Cutera, Inc.
Anne Werdan
Director, Investor Relations
415-657-5500
awerdan@cutera.com

Source: Cutera, Inc.